Correlation Between MAIA Biotechnology and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Purple Biotech, you can compare the effects of market volatilities on MAIA Biotechnology and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Purple Biotech.
Diversification Opportunities for MAIA Biotechnology and Purple Biotech
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between MAIA and Purple is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Purple Biotech go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Purple Biotech
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 0.81 times more return on investment than Purple Biotech. However, MAIA Biotechnology is 1.23 times less risky than Purple Biotech. It trades about -0.13 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.35 per unit of risk. If you would invest 266.00 in MAIA Biotechnology on August 24, 2024 and sell it today you would lose (51.00) from holding MAIA Biotechnology or give up 19.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MAIA Biotechnology vs. Purple Biotech
Performance |
| Timeline |
| MAIA Biotechnology |
| Purple Biotech |
MAIA Biotechnology and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Purple Biotech
The main advantage of trading using opposite MAIA Biotechnology and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |